We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCTX icon
3726
Lineage Cell Therapeutics
LCTX
$283M
-201,447
Closed -$91K
LNZA icon
3727
LanzaTech
LNZA
$69M
-779
Closed -$18.9K
LSEA
3728
DELISTED
Landsea Homes
LSEA
-27,894
Closed -$179K
LVO icon
3729
LiveOne
LVO
$62.8M
-5,777
Closed -$40.4K
LWLG icon
3730
Lightwave Logic
LWLG
$1.16B
-159,275
Closed -$163K
LXRX icon
3731
Lexicon Pharmaceuticals
LXRX
$1.08B
-137,230
Closed -$88.9K
LYEL icon
3732
Lyell Immunopharma
LYEL
$365M
-11,785
Closed -$127K
LYRA
3733
DELISTED
LYRA THERAPEUTICS INC
LYRA
-1,754
Closed -$11K
MBLY icon
3734
Mobileye
MBLY
$7.54B
-1,870
Closed -$26.9K
MGNX icon
3735
MacroGenics
MGNX
$249M
-87,215
Closed -$111K
MOLN
3736
Molecular Partners
MOLN
$155M
-269
Closed -$1.09K
MRAM icon
3737
Everspin Technologies
MRAM
$400M
-36,835
Closed -$188K
MRSN
3738
DELISTED
Mersana Therapeutics
MRSN
-6,167
Closed -$53K
NAUT icon
3739
Nautilus Biotechnolgy
NAUT
$113M
-69,755
Closed -$60K
NKTR icon
3740
Nektar Therapeutics
NKTR
$2.55B
-14,784
Closed -$151K
NNBR icon
3741
NN Inc
NNBR
$301M
-43,282
Closed -$97.8K
NOTE
3742
DELISTED
FiscalNote
NOTE
-4,801
Closed -$46.5K
NOVA
3743
DELISTED
Sunnova Energy
NOVA
-152,799
Closed -$56.8K
NRGV icon
3744
Energy Vault
NRGV
$649M
-149,636
Closed -$104K
NTIC icon
3745
Northern Technologies International Corp
NTIC
$76.2M
-6,813
Closed -$70.9K
OBIO icon
3746
Orchestra BioMed
OBIO
$264M
-31,657
Closed -$135K
OCGN icon
3747
Ocugen
OCGN
$465M
-345,130
Closed -$244K
OPAD icon
3748
Offerpad Solutions
OPAD
$23M
-1,223
Closed -$20.3K
OPEN icon
3749
Opendoor
OPEN
$3.48B
-936,346
Closed -$924K
OTLK icon
3750
Outlook Therapeutics
OTLK
$211M
-16,170
Closed -$19.7K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.